Methodological Considerations in the Interpretation of Non-invasive Surrogate Markers in a Post Hoc Analysis of Pemafibrate in Metabolic Dysfunction–associated Steatotic Liver Disease
Methodological Considerations in the Interpretation of Non-invasive Surrogate Markers in a Post Hoc Analysis of Pemafibrate in Metabolic Dysfunction–associated Steatotic Liver Disease. // Journal of Clinical and Experimental Hepatology. – URL: https://www.sciencedirect.com/science/article/pii/S0973688326001465?dgcid=rss_sd_all
Methodological Considerations in the Interpretation of Non-invasive Surrogate Markers in a Post Hoc Analysis of Pemafibrate in Metabolic Dysfunction–associated Steatotic Liver Disease. Journal of Clinical and Experimental Hepatology. https://www.sciencedirect.com/science/article/pii/S0973688326001465?dgcid=rss_sd_all
“Methodological Considerations in the Interpretation of Non-invasive Surrogate Markers in a Post Hoc Analysis of Pemafibrate in Metabolic Dysfunction–associated Steatotic Liver Disease.” Journal of Clinical and Experimental Hepatology.
@article{article52596,
title = {Methodological Considerations in the Interpretation of Non-invasive Surrogate Markers in a Post Hoc Analysis of Pemafibrate in Metabolic Dysfunction–associated Steatotic Liver Disease},
journal = {Journal of Clinical and Experimental Hepatology},
url = {https://www.sciencedirect.com/science/article/pii/S0973688326001465?dgcid=rss_sd_all}
}